In a recent paper, economists from West Virginia University (WVU) examine how COVID-19 has strained the health care industry and offer their own expertise on how to address primary care shortages.
Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use. And with minor changes, Northwestern University investigators hope the same vaccine platform could target other infectious diseases.
Bay Area Health Trust has today announced its receipt of a Health Canada Interim Order authorization for its McMaster Molecular Medium (MMM). A temperature-stable molecular transport medium, MMM inactivates and stabilizes COVID-19 specimens from the collection site to the laboratory. More than 3 million units of MMM have already been deployed in Ontario as part of Public Health Ontario's approved list of COVID-19 PCR collection kits that contain a swab and vial with transport media, like MMM.
MicroRNAs in urine could prove to be promising biomarkers in clinical laboratory tests designed to diagnose brain tumors regardless of the tumor’s size or malignancy, paving the way for early detection and treatment.
Blood levels of a biomarker called glial fibrillary acidic protein (GFAP) may uniquely aid prediction of dementia in Mexican Americans.
Aligning with Brain Awareness Week, a study published in Nature Neuroscience integrated whole genome sequencing with multi-omics datasets. The remarkable genetic diversity in the human brain is being illuminated with the discovery of more than 170,000 genetic structural variants.
A multidisciplinary team of researchers from Roswell Park Comprehensive Cancer Center and Kaiser Permanente Northern California have identified the first pharmacogenomic marker for anthracyclines and HER2-targeting drugs, two commonly used breast cancer chemotherapies.
Engineers and scientists have developed proof of concept for a robot that can reach some of the smallest bronchial tubes in the lungs - to take tissue samples or deliver cancer therapy.
Successfully addressing bias, discrimination, bullying, and harassment in the workplace requires institutional dedication; visible, supportive leadership; and adequate financial resources for implementing effective policies and procedures, according to an American College of Cardiology (ACC) health policy statement recently published.
A genome-wide association study examines whether or not your genes make you a better leader.
We need your help to grow this newsletter! Please pass along the subscription link to any colleague you think would benefit from hearing about med lab news.